Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis
Authors:
- 1 March 2005
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (S1) , S27-S29
Abstract
Autologous stem cell transplantation (ASCT) can be performed in a variety of refractory autoimmune diseases. A retrospective multicenter analysis is presented to evaluate safety and efficacy of ASCT for refractory juvenile idiopathic arthritis. In all, 18 of the 34 patients (53%) with a follow-up of 12 to 60 months achieved a drug-free complete remission. There were three cases (9%) of transplant-related mortality and two cases of disease-related mortality (6%). Infectious complications were seen frequently. We propose adjustments in future protocols to reduce this mortality in this high-risk patient group.Keywords
This publication has 17 references indexed in Scilit:
- Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidityAnnals of the Rheumatic Diseases, 2004
- Coincidental autoimmune disease in patients transplanted for conventional indicationsBest Practice & Research Clinical Haematology, 2004
- Preclinical experimentsBest Practice & Research Clinical Haematology, 2004
- Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritisBone Marrow Transplantation, 2003
- Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis & Rheumatism, 2003
- Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: A multicenter cohort studyArthritis & Rheumatism, 2000
- Etanercept in Children with Polyarticular Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic‐onset juvenile rheumatoid arthritisArthritis & Rheumatism, 1997
- Preliminary definition of improvement in juvenile arthritisArthritis & Rheumatism, 1997
- Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporineThe Journal of Pediatrics, 1996